![](/img/cover-not-exists.png)
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer
Lanting Lu, Jaime Peters, Chris Roome, Ken SteinVolume:
109
Year:
2012
Language:
english
DOI:
10.1111/j.1464-410x.2011.10434.x
File:
PDF, 601 KB
english, 2012